Atlas Trials

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

Clinical trial NCT01230957 · COMPLETED

Trial details

NCT number
NCT01230957
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Clostridium Difficile InfectionDiarrhea
Start date
2010-10-01
Primary completion
2012-11-01
Enrollment
650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.